Search
eXoZymes Inc
EXOZAdd to Watchlist
8.575USD
+0.075+0.88%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
72.71MMarket Cap
LossP/E TTM
More Details of eXoZymes Inc Company
eXoZymes Inc, formerly Invizyne Technologies, Inc., is an artificial intelligence (AI) engineered enzyme that can transform sustainable feedstock into essential chemicals, medicines, and biofuels. The Company has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
eXoZymes Inc Info
Ticker SymbolEXOZ
Company nameeXoZymes Inc
IPO dateNov 13, 2024
CEOHeltzen (Michael)
Number of employees31
Security typeOrdinary Share
Fiscal year-endNov 13
Address750 Royal Oaks Dr
CityMONROVIA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code91016
Phone16264151488
Websitehttps://exozymes.com/
Ticker SymbolEXOZ
IPO dateNov 13, 2024
CEOHeltzen (Michael)
Company Executives of eXoZymes Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
Mr. Anthony DiGiandomenico
Mr. Anthony DiGiandomenico
Director
Director
--
--
Dr. James U. Bowie, Ph.D.
Dr. James U. Bowie, Ph.D.
Independent Director
Independent Director
--
--
Dr. James J. (Jim) Lalonde, Ph.D.
Dr. James J. (Jim) Lalonde, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lon Edward Bell, Ph.D.
Dr. Lon Edward Bell, Ph.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Paul Hideo Opgenorth, Ph.D.
Dr. Paul Hideo Opgenorth, Ph.D.
Vice President - Development
Vice President - Development
647.49K
+0.62%
Mr. Edgardo Rayo
Mr. Edgardo Rayo
Director
Director
77.91K
--
Mr. Fouad Nawaz
Mr. Fouad Nawaz
Vice President - Finance
Vice President - Finance
9.49K
+63.23%
Mr. Michael Heltzen
Mr. Michael Heltzen
Chief Executive Officer
Chief Executive Officer
--
-100.00%
Dr. Tyler Korman, Ph.D.
Dr. Tyler Korman, Ph.D.
Vice President - Research
Vice President - Research
--
--
Mr. Christopher A. (Chris) Marlett
Mr. Christopher A. (Chris) Marlett
Chairman of the Board
Chairman of the Board
--
--
FAQs
Who are the top five shareholders of eXoZymes Inc?
The top five shareholders of eXoZymes Inc are: Dr. Paul Hideo Opgenorth, Ph.D.
How many institutions hold shares of eXoZymes Inc (EXOZ)?
As of 2026Q1, 13 institutions hold shares of eXoZymes Inc, with a combined market value of approximately 94.24K, accounting for 1.11% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 16676.00.